PAN Foundation Launches New Disease Funds to Assist Patients with MRSA and Short Bowel Syndrome
Washington, D.C., January 2, 2013 – Patient Access Network (PAN) Foundation is pleased to announce the launch of two new funds at the start of the year. Patients with Methicillin-resistant Staphylococcus aureus (MRSA) infections and Short Bowel Syndrome will now have increased access to live-saving specialty medications through PAN’s financial assistance programs.
“PAN’s ease of application and quick turnaround time ensures patients are placed on a fast track to therapy,” explained Patrick McKercher, PAN President. “More than two thirds of PAN patients surveyed in 2012 stated that PAN’s assistance led to decreased stress levels, and our patient-friendly program features certainly contribute to that,” Dr. McKercher continued.
Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium responsible for several difficult-to-treat infections in humans. MRSA is any strain of Staphylococcus aureus that has developed resistance to beta-lactam antibiotics, which include the penicillins and the cephalosporins. MRSA is especially troublesome in hospitals, prisons, schools, and nursing homes, where patients with open wounds, invasive devices, and weakened immune systems are at greater risk of infection than the general public.
Short bowel syndrome is a condition in which nutrients are not properly absorbed because a large part of the small intestine is missing or has been surgically removed. When areas of the small intestine are removed by surgery, or they are missing due to a birth defect (congenital defect), there may not be enough surface area left in the remaining bowel to absorb enough nutrients from food. This condition is likely to develop when one-half or more of the bowel is removed during surgery. Risk factors include diseases of the small intestine that may require surgery, such as Crohn's disease. Necrotizing enterocolitis is a common cause of short bowel syndrome in infants.
About PAN Foundation
Patient Access Network (PAN) Foundation is an independent, national 501c3 organization dedicated to providing underinsured patients much needed financial assistance to cover out-of-pocket expenses related to qualifying treatments. PAN provides grants of $500 to $10,000 per year to qualified patients to help pay for medications for more than 40 cancers, chronic illnesses and rare diseases. Since 2004, PAN has provided more hundreds of millions of dollars in assistance for out-of-pocket expenses to hundreds of thousands of patients in need. For more information, visit www.PANfoundation.org.